Skip to main content

Table 1 Characteristics of the total cohort and by sex

From: Systemic arteriosclerosis is associated with left ventricular remodeling but not atherosclerosis: a TASCFORCE study

 

Total

Men

Women

p-value

N

1515

574

941

 

Age (years)

54.1 ± 8.3

53.8 ± 8.2

54.3 ± 8.4

0.24

Heart rate (bpm)

63.4 ± 10.0

61.4 ± 9.7

64.6 ± 9.9

< 0.001

Systolic BP (mmHg)

122 ± 12

125 ± 11

121 ± 12.5

< 0.001

Diastolic BP (mmHg)

73 ± 9

75 ± 9

72 ± 9

< 0.001

BMI (kg/m2)

26.8 ± 4.3

27.1 ± 3.6

26.6 ± 4.6

0.025

Current smoker (%)

165 (10.9%)

51 (8.9%)

114 (12.1%)

0.057

Ex smoker (%)

414 (27.4%)

162 (28.3%)

252 (26.8%)

0.52

Non-smoker (%)

935 (61.8%)

360 (62.8%)

575 (61.1%)

0.53

Smoking pack years

6.03 ± 11.9

6.64 ± 13.7

5.65 ± 10.6

0.12

Family history of CVD

387 (25.5%)

131 (22.8%)

256 (27.2%)

0.058

Total cholesterol (mmol/L)

5.48 ± 0.97

5.40 ± 0.92

5.53 ± 1.0

0.016

LDL-Cholesterol (mmol/L)

3.40 ± 0.88

3.40 ± 0.83

3.39 ± 0.90

0.83

HDL-Cholesterol (mmol/L)

1.44 ± 0.43

1.25 ± 0.39

1.56 ± 0.41

< 0.001

Triglycerides (mmol/L)

1.47 ± 0.86

1.71 ± 0.96

1.32 ± 0.75

< 0.001

Random glucose (mmol/L)

5.18 ± 0.90

5.27 ± 0.78

5.11 ± 0.97

0.018

BNP (pg/ml)

27.4 ± 17.9

19.8 ± 13.7

32.1 ± 18.5

< 0.001

ASSIGN risk score (%)

9.3 ± 6.6

11.4 ± 6.5

7.9 ± 6.3

< 0.001

LVEDV (g/m2)

71.6 ± 12.4

77.3 ± 13.2

68.1 ± 10.5

< 0.001

LVESV (g/m2)

22.6 ± 7.1

25.0 ± 7.4

21.1 ± 6.6

< 0.001

LVSV (g/m2)

49.0 ± 8.3

52.2 ± 8.9

47.0 ± 7.2

< 0.001

LVEF (%)

68.8 ± 6.5

67.9 ± 6.2

69.3 ± 6.6

< 0.001

LV mass (g/m2)

55.1 ± 11.6

64.3 ± 10.6

49.5 ± 8.0

< 0.001

LVMVR (g/ml)

0.78 ± 0.15

0.85 ± 0.16

0.74 ± 0.13

< 0.001

Compliance (ml/m2/mmHg)

1.03 ± 0.28

1.17 ± 1.96

0.99 ± 0.27

< 0.001

SAS

1.27 ± 2.1

1.17 ± 1.96

1.34 ± 2.18

0.14

SIMD

 1

65 (4.3%)

20 (2.1%)

45 (4.8%)

0.72

 2

78 (5.2%)

25 (4.4%)

53 (5.7%)

 3

101 (6.7%)

36 (6.3%)

65 (6.9%)

 4

77 (5.1%)

34 (5.9%)

43 (4.6%)

 5

93 (6.2%)

34 (5.9%)

59 (6.3%)

 6

165 (10.9%)

63 (11%)

102 (10.9%)

 7

246 (16.3%)

88 (15.3%)

158 (16.8%)

 8

295 (19.5%)

115 (20%)

180 (19.2%)

 9

275 (18.2%)

109 (19%)

166 (17.7%)

 10

117 (7.7%)

50 (3.3%)

67 (7.1%)

  1. ASSIGN Assessing cardiovascular risk using SIGN guidelines, BMI body mass index, BNP brain natriuretic peptide, BP blood pressure, CVD cardiovascular disease, HDL high density lipoprotein, LDL low density lipoprotein, LVEDV left ventricular end diastolic volume, LVESV left ventricular end systolic volume, LVSV left ventricular stroke volume, LVEF left ventricular ejection fraction, LVMVR left ventricular mass to volume ratio, SAS standardised atheroma score, SIMD Scottish Index of Multiple Deprivation
  2. P-values < 0.05 highlighted in bold